Rezo Therapeutics

San Francisco, United States · Founded 2021

Employees
11–50
Founded
2021
Business Model
B2B
Website
rezotx.com
Last Round
Series BAug 2025
Rounds
2

About

Rezo integrates proteomics, genetics, structural biology, chemistry, and bioinformatics to create comprehensive maps of molecular disease networks, with the aim of identifying novel, druggable targets for precision therapeutics — with an initial focus on oncology. Rezo is mapping disease networks to unlock a new era of drug discovery and find unique insights of disease biology.

Summary

Rezo Therapeutics is an Artificial Intelligence company based in San Francisco, United States, founded in 2021. Its most recent funding was a Series B round in Aug 2025. Investors include SR One, Andreessen Horowitz and Norwest Venture Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BAug 2025

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Rezo Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/rezo-therapeutics"><img src="https://indexed.vc/api/badge/company/rezo-therapeutics" alt="Rezo Therapeutics on Indexed.vc" width="260" height="76" /></a>